Literature DB >> 25500054

From actinic keratosis to squamous cell carcinoma: evidence of morphologic and biologic progression.

Cristel Ruini1, Alexander Michael Witkowski1, Annamaria Cesinaro2, Nathalie Teixeira De Carvalho1, Giovanni Pellacani3.   

Abstract

Entities:  

Mesh:

Year:  2015        PMID: 25500054     DOI: 10.1016/j.jaad.2014.02.046

Source DB:  PubMed          Journal:  J Am Acad Dermatol        ISSN: 0190-9622            Impact factor:   11.527


× No keyword cloud information.
  5 in total

1.  Acantholytic squamous cell carcinoma is usually associated with hair follicles, not acantholytic actinic keratosis, and is not "high risk": Diagnosis, management, and clinical outcomes in a series of 115 cases.

Authors:  Toru Ogawa; Maija Kiuru; Thomas H Konia; Maxwell A Fung
Journal:  J Am Acad Dermatol       Date:  2016-11-23       Impact factor: 11.527

Review 2.  The Role of p16INK4a Pathway in Human Epidermal Stem Cell Self-Renewal, Aging and Cancer.

Authors:  Daniela D'Arcangelo; Lavinia Tinaburri; Elena Dellambra
Journal:  Int J Mol Sci       Date:  2017-07-22       Impact factor: 5.923

Review 3.  New insights from non-invasive imaging: from prospection of skin photodamages to training with mobile application.

Authors:  G Pellacani; G Argenziano
Journal:  J Eur Acad Dermatol Venereol       Date:  2022-06       Impact factor: 9.228

Review 4.  Clinical Characteristics of Actinic Keratosis Associated with the Risk of Progression to Invasive Squamous Cell Carcinoma: A Systematic Review.

Authors:  Alise Balcere; Laura Konrāde-Jilmaza; Laura Agnese Pauliņa; Ingrīda Čēma; Angelika Krūmiņa
Journal:  J Clin Med       Date:  2022-10-06       Impact factor: 4.964

5.  MiR-204 silencing in intraepithelial to invasive cutaneous squamous cell carcinoma progression.

Authors:  Agustí Toll; Rocío Salgado; Blanca Espinet; Angel Díaz-Lagares; Eugenia Hernández-Ruiz; Evelyn Andrades; Juan Sandoval; Manel Esteller; Ramón M Pujol; Inmaculada Hernández-Muñoz
Journal:  Mol Cancer       Date:  2016-07-25       Impact factor: 27.401

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.